Please use this identifier to cite or link to this item:
http://hdl.handle.net/10400.18/5182| Title: | Halting Schistosoma haematobium - Associated Bladder Cancer |
| Author: | Botelho, Monica C. Alves, Helena Joachim, Richter |
| Keywords: | Schistosomiasis Bladder Cancer Mass Treatment Bladder Cancer |
| Issue Date: | 30-Sep-2017 |
| Publisher: | American Association for Cancer Research |
| Citation: | Int J Cancer Manag. 2017;10(9). pii: e9430. doi: 10.5812/ijcm.9430. Epub 2017 Sep 30 |
| Abstract: | Background: At present schistosomiasis is endemic in 78 countries, affecting more than 260 million people. Schistosomiasis haematobia alone affects more than 112 millions. Evidence Acquisition: We performed a computerized search of in PubMed database with keywords: Bladder Cancer Cost and Schistosomiasis Mass Treatment. Results: Bladder cancer is an important sequelae of this infection. In low-resource countries, where this disease is endemic, individuals inflicted with bladder cancer have very limited access to treatment and death is most probably certain. Conclusions: Mass treatment with praziquantel is an easy, safe, and inexpensive treatment that could save the lives of thousands and reduce the morbidity of millions. |
| Peer review: | yes |
| URI: | http://hdl.handle.net/10400.18/5182 |
| DOI: | 10.5812/ijcm.9430. |
| ISSN: | 2538-497X 2538-4422 |
| Publisher Version: | http://ijcancerprevention.com/en/articles/9430.html |
| Appears in Collections: | DPSPDNT - Artigos em revistas internacionais |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Halting Schistosoma haematobium - Associated Bladder Cancer.pdf | 101,35 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.













